Use of lamin b1 nuclear antigen, fragments and compositions...

Details Use of lamin b1 nuclear antigen, fragments and compositions... Use of lamin b1 nuclear antigen, fragments and compositions...

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61P 7/02 (2006.01)

Patent

CA 2572816

A method for preventing a thrombotic event in a patient susceptible to such an event, which comprises the step of administering an effective amount of a lamin 131 nuclear (LB1) antigen to said patient is provided along with an anti- thrombotic composition which comprises an effective amount of a lamin 131 nuclear (LB1) antigen and a pharmaceutically acceptable carrier.

Cette invention concerne un procédé pour prévenir un événement thrombotique chez un patient susceptible de souffrir d'un tel événement, ce procédé consistant à administrer à ce patient une quantité efficace d'un antigène nucléaire de lamine B1 (LB1), ainsi qu'une composition anti-thrombose qui comprend une quantité efficace d'un antigène nucléaire de lamine B1 (LB1) et un excipient acceptable sur le plan pharmaceutique.

Affiliated with

Also associated with

Rating

Use of lamin b1 nuclear antigen, fragments and compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of lamin b1 nuclear antigen, fragments and compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lamin b1 nuclear antigen, fragments and compositions... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1528138